Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/23/2008US20080262055 Macrocyclic Acyl Guanidines as Beta-Secretase Inhibitors
10/23/2008US20080262053 continuous treatment with pramipexole even over 6 months or more leads to a lasting improvement in the RLS symptoms
10/23/2008US20080262052 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one
10/23/2008US20080262050 Organic Compounds
10/23/2008US20080262047 Ppar-Gamma Agonists for Improvement of Cognitive Function in Apoe4 Negative Patients
10/23/2008US20080262046 Amidopropoxyphenyl Orexin Receptor Antagonists
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262041 Beta-Lactams for Treatment of Cns Disorders
10/23/2008US20080262040 novel indazole carboxamide derivatives for inflammatory and tissue repair disorders like rheumatoid arthritis, asthma, and COPD; kinase inhibitors in particular IKK2; 1,1-dimethylethyl-4-[4-(aminocarbonyl)-6-phenyl-1H-indazol-1-yl]-1-piperidinecarboxylate; intermediates
10/23/2008US20080262039 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions
10/23/2008US20080262038 4-[(4-aminophenyl)(1-benzylpiperidin-4-ylidene)methyl]-N,N-diethylbenzamide; management of pain, anxiety and functional gastrointestinal disorders; delta agonist
10/23/2008US20080262035 Amide Derivatives as Inhibitors of Histone Deacetylase
10/23/2008US20080262032 Isoxazoline Derivative and Novel Process for Its Preparation
10/23/2008US20080262030 Drug for psychological and central nervous system disorders
10/23/2008US20080262029 Acid and Base Salt Forms of Gaboxadol
10/23/2008US20080262026 1-(2,4-dichlorophenyl)-2-{4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl}-3-methyl-5-piperidin-1-yl-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one; obesity, psychiatric and neurological disorders
10/23/2008US20080262025 Processes for the Preparation of Zolpidem and its Hemitartrate
10/23/2008US20080262023 Aminomethyl Azaadamantane Derivatives and Methods of Use Thereof
10/23/2008US20080262019 Optical Isomers of (+) and (-)-Trans-2,3,4,4A,5,9B-Hexahydro-2,8-Dimethyl-1H-Pyrido[4,3-B] Indole
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080262013 Oxymorphone controlled release formulations
10/23/2008US20080262011 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors
10/23/2008US20080262004 4-[2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-1H-pyrrolo[2,3-b]pyridine; to treat autoimmune disorders like rheumatoid arthritis, glomerulonephritis, neoplasms; antifibrotic agents
10/23/2008US20080261999 Azabicycloalkane Derivatives Useful as Nicotinic Acetylcholine Receptor Agonists
10/23/2008US20080261997 Use of aminoindazole derivatives for the inhibition of tau phosphorylation
10/23/2008US20080261992 Pyridin-2-One Compounds and Their Use as Modulators of the Dopamine D3 Receptor
10/23/2008US20080261984 Use of S,S-Reboxetine in the Treatment of Pain
10/23/2008US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
10/23/2008US20080261972 Cgrp Receptor Antagonists
10/23/2008US20080261971 Novel Heterocyclic Nf-Kb Inhibitors
10/23/2008US20080261967 Modulators of Central Nervous System Neurotransmitters
10/23/2008US20080261955 disorders associated with noradreanaline reuptake, such as attention deficit disorder, Chronic Fatigue Syndrome, fibromyalgia, and depression with pain
10/23/2008US20080261954 derived (either formally by their chemical structure or directly by chemical synthesis) from natural compounds belonging to the class of amaryllidaceae alkaloids e.g. Galanthamine, narwedine and lycoramine, or from metabolites of said compounds
10/23/2008US20080261953 Compounds, Compositions and Methods of Inhibiting Alpha-Synuclein Toxicity
10/23/2008US20080261950 Drug hybrid of rivastigmine or physostigmine with tranylcypromine, amoxapine, desipramine, nortriptyline, protriptyline, fluoxetine, fluvoxamine, paroxetine, duloxetine, betahistine, amlodipine, proylhexedrine, rimantadine, desloratadine; Alzheimer's disease; Parkinson's disease, impairment in memory
10/23/2008US20080261948 Ligands for G-Protein Coupled Receptors
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261945 Compounds Having Activity at Nk3 Receptor and Uses Thereof in Medicine
10/23/2008US20080261941 Inhibitors of fatty acid amide hydrolase; N-pyridin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide; elevate brain anandamide levels; pain, urinary incontinence, cognitive disorders, anxiety, depression, sleeping, eating, movement disorders, glaucoma, psoriasis
10/23/2008US20080261922 Pharmacological Treatments for Sleep Disorders (Apnoe) With Prostanoid Receptor Antagonists
10/23/2008US20080261918 Silicon Compounds and Their Use
10/23/2008US20080261881 Diluted in physiological saline, with or without the addition of human albumin or cyclodextrin
10/23/2008US20080261879 Activin (follistatin) receptors; inhibin; neuronal differentiation; transforming growth factors
10/23/2008US20080261878 In-vivo assay; tau protein; amyloid precursor proteins; neurodegenerative diseases
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261303 Method and medicament for inhibiting the expression of a given gene
10/23/2008US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080260873 Agent for prevention or improvement of neuropathy comprising pre-germinated brown rice lipid fraction as an effective ingredient
10/23/2008US20080260871 Method and composition for infusing herbal extracts and pharmaceuticals through the skin
10/23/2008US20080260866 Method for decreasing inflammation and stress in a mammal
10/23/2008US20080260846 Has acceptable biodegradable polymer; polyglycolic acid, polylactic acid; Parkinson's Disease; injectable microspheres, injectable gels and implants; enhanced bioavailability
10/23/2008US20080260834 Localized delivery of 1,25 D3 directly to target area using biodegradable polymeric matrices maximizes the efficacy of drug while minimizing systemic exposure and toxicity; inhibit tumor viability or proliferation
10/23/2008US20080260830 suitable for regeneration, growth stimulation and differentiation of various cells, tissues and organs; growth/differentiation factors (GDFs); regeneration of connective tissue including tendon and/or ligament, periodontal or dental tissue including dental implants, neural tissue and sensory tissues
10/23/2008US20080260825 Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
10/23/2008US20080260813 Pharmaceutical composition of topiramate
10/23/2008US20080260807 Water-Soluble Films Comprising Nicotine
10/23/2008US20080260797 Methods of treating disease with nitric oxide (no)-releasing polymers and soluble no-releasing nitrosamines
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260746 Erythropoietin polypeptide for use in treatment and prevention of viral, skin, nervous system, autoimmune, cardiovascular, kidney, cell proliferative and cardiovascular disorders
10/23/2008US20080260744 Using neuronal membrane protein receptor as screening tool in identifying modulators for treatment of brain disorders
10/23/2008US20080260728 Using very late antigen-4 (VLA-4) specific immunoglobulins for prevention and treatment of autoimmune diseases
10/23/2008US20080260718 Phospholipase C Gamma Modulation and Uses Thereof for Management of Pain and Nociception
10/23/2008US20080260717 Methods for Reducing Seizure-Induced Neuronal Damage
10/23/2008US20080260699 Adminstration of intact mammalian cells to the brain by the intranasal route
10/23/2008US20080260688 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/23/2008US20080260643 Use of pde7 inhibitors for the treatment of movement disorders
10/23/2008DE102007018151A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/23/2008DE102007018150A1 Treating pain, using dual action compound or combination of compounds with affinity for both mu-opioid and vanilloid VR1-receptors, also effective e.g. against coughs or asthma
10/23/2008CA2683797A1 Means and methods for counteracting protein aggregation
10/23/2008CA2683719A1 N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
10/23/2008CA2683586A1 Substituted furo[2,3-beta]pyridine derivatives as cannabinoid 1-receptor modulators
10/23/2008CA2683580A1 Treatment of amyotrophic lateral sclerosis
10/23/2008CA2683548A1 Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
10/23/2008CA2683546A1 Use of cyclohexanehexol derivatives in the treatment of .alpha.-synucleinopathies
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/23/2008CA2682855A1 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
10/23/2008CA2682817A1 Pyrimidinyl-piperazines useful as d3/d2 receptor ligands
10/23/2008CA2682598A1 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
10/23/2008CA2681787A1 Heterocyclic compounds and their methods of use
10/23/2008CA2681596A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
10/23/2008CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008CA2678433A1 Pyrano-pyrazole-amines
10/23/2008CA2678134A1 Spiro-pyrano-pyrazole derivatives
10/23/2008CA2668305A1 Azaindole derivatives as cftr modulators
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982987A1 Spiro-pyrano-pyrazole derivatives
10/22/2008EP1982970A1 Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
10/22/2008EP1982729A1 Vaccination Regimen for B-Cell Vaccines
10/22/2008EP1982721A1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition
10/22/2008EP1982716A1 Novel histidine derivative
10/22/2008EP1982714A1 Pyrano-pyrazole-amines
10/22/2008EP1982713A2 Substituted benzoxazoles and analogues as estrogenic agents
10/22/2008EP1982704A2 New molecular target of neurotoxicity
10/22/2008EP1981974A2 Compositions and methods for treating lysosomal storage diseases
10/22/2008EP1981901A1 Amino acid derivatives
10/22/2008EP1981887A2 Pyrrolo[2,3,b]pyridine derivatives useful as raf kinase inhibitors
10/22/2008EP1981885A2 A method of preparing a 4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor
10/22/2008EP1981883A1 Novel heteroaryl substituted benzothiazoles
1 ... 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 ... 1833